Kaoru Terada

892 total citations
30 papers, 642 citations indexed

About

Kaoru Terada is a scholar working on Immunology, Rheumatology and Agronomy and Crop Science. According to data from OpenAlex, Kaoru Terada has authored 30 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Rheumatology and 7 papers in Agronomy and Crop Science. Recurrent topics in Kaoru Terada's work include T-cell and Retrovirus Studies (8 papers), Animal Disease Management and Epidemiology (7 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Kaoru Terada is often cited by papers focused on T-cell and Retrovirus Studies (8 papers), Animal Disease Management and Epidemiology (7 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Kaoru Terada collaborates with scholars based in Japan. Kaoru Terada's co-authors include Atsushi Kawakami, Shigenobu Nagataki, Masahiro Sakai, Izumi Yamashita, Shigeru Katamine, Yoshiki Kawabe, Katsumi Eguchi, Yasukuni Tsuji, Masako Kita and Toru Miyamoto and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Kaoru Terada

27 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaoru Terada Japan 13 391 202 150 130 95 30 642
M Shirao Japan 7 553 1.4× 299 1.5× 269 1.8× 53 0.4× 87 0.9× 10 978
Koichiro Suemori Japan 14 383 1.0× 190 0.9× 182 1.2× 65 0.5× 48 0.5× 38 665
Z. N. Berneman Belgium 11 198 0.5× 117 0.6× 116 0.8× 30 0.2× 129 1.4× 28 509
Grace Clarke United States 7 494 1.3× 53 0.3× 37 0.2× 360 2.8× 125 1.3× 8 1.1k
George Bourikas Greece 12 562 1.4× 261 1.3× 246 1.6× 28 0.2× 27 0.3× 21 776
Isao Sanada Japan 13 432 1.1× 226 1.1× 245 1.6× 25 0.2× 22 0.2× 36 712
Claude Kasten-Sportès United States 17 655 1.7× 98 0.5× 124 0.8× 18 0.1× 89 0.9× 24 1.0k
S D Nimer United States 14 340 0.9× 89 0.4× 83 0.6× 21 0.2× 14 0.1× 21 947
Satoko Morishima Japan 21 665 1.7× 38 0.2× 42 0.3× 33 0.3× 82 0.9× 71 1.2k
Daisuke Imanishi Japan 14 195 0.5× 69 0.3× 86 0.6× 12 0.1× 27 0.3× 38 431

Countries citing papers authored by Kaoru Terada

Since Specialization
Citations

This map shows the geographic impact of Kaoru Terada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Terada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Terada more than expected).

Fields of papers citing papers by Kaoru Terada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaoru Terada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Terada. The network helps show where Kaoru Terada may publish in the future.

Co-authorship network of co-authors of Kaoru Terada

This figure shows the co-authorship network connecting the top 25 collaborators of Kaoru Terada. A scholar is included among the top collaborators of Kaoru Terada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaoru Terada. Kaoru Terada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Eguchi, Katsumi, et al.. (2024). Comparative analysis of renal decline rates in microscopic polyangiitis: unveiling the slowly progressive phenotype. Immunological Medicine. 47(4). 254–263.
3.
Kobayashi, Tsutomu, Noriko Iwamoto, Kaoru Terada, et al.. (2024). Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient. Scandinavian Journal of Rheumatology. 54(1). 61–63.
4.
5.
Takatani, Ayuko, Naoki Iwamoto, Toshiyuki Aramaki, et al.. (2023). Impact of SARS-CoV-2 mRNA vaccine on arthritis condition in rheumatoid arthritis. Frontiers in Immunology. 14. 1256655–1256655. 2 indexed citations
6.
Eguchi, Katsumi, et al.. (2023). Hypocomplementemic urticarial vasculitis case with hemophagocytic lymphohistiocytosis following SARS-CoV-2 mRNA vaccination. Immunological Medicine. 46(2). 97–107. 5 indexed citations
9.
Aramaki, Toshiyuki, Yukitaka Ueki, Kanako Kojima, et al.. (2018). AB0315 High disease activity at baseline, not rf nor acpa status, predicts inadequate response to methotrexate (MTX) in patients with early rheumatoid arthritis in real world: a single centrecohort in japan. Annals of the Rheumatic Diseases. 77. 1334–1334. 1 indexed citations
10.
Iwamoto, Naoki, Ayuko Takatani, Toshimasa Shimizu, et al.. (2017). Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis. PLoS ONE. 12(5). e0177057–e0177057. 23 indexed citations
11.
Kawashiri, Shin‐ya, Yukitaka Ueki, Kaoru Terada, et al.. (2013). Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy. Rheumatology International. 34(2). 221–225. 19 indexed citations
12.
Mori, Shunsuke, Kaoru Terada, & Yukitaka Ueki. (2012). Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms. Modern Rheumatology. 22(4). 515–523. 2 indexed citations
13.
Origuchi, Tomoki, Kazuhiko Arima, Shin‐ya Kawashiri, et al.. (2011). High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome. Modern Rheumatology. 22(4). 584–588. 31 indexed citations
14.
Mori, Shunsuke, Kaoru Terada, & Yukitaka Ueki. (2011). Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms. Modern Rheumatology. 22(4). 515–523. 2 indexed citations
15.
Terada, Kaoru, Shigeru Katamine, Toru Miyamoto, et al.. (1994). Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. The Lancet. 344(8930). 1116–1119. 184 indexed citations
16.
Katamine, Shigeru, R Moriuchi, Taro Yamamoto, et al.. (1994). HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. The Lancet. 343(8909). 1326–1327. 23 indexed citations
17.
Kawakami, Atsushi, Munetoshi Nakashima, Hiroaki Ida, et al.. (1993). Stimulation of mitogenesis in human thyroid epithelial cells by endothelin. European Journal of Endocrinology. 128(3). 215–220. 18 indexed citations
18.
Eguchi, Katsumi, Ayako Kawakami, Hiroaki Ida, et al.. (1992). Bucillamine inhibits T cell adhesion to human endothelial cells.. PubMed. 19(7). 1045–50. 11 indexed citations
19.
Eguchi, Katsumi, Atsushi Kawakami, Megan O. Nakashima, et al.. (1992). Interferon-alpha and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells. Clinical & Experimental Immunology. 88(3). 448–454. 38 indexed citations
20.
Eguchi, Katsuyuki, N. Matsuoka, Hiroaki Ida, et al.. (1992). Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.. Annals of the Rheumatic Diseases. 51(6). 769–776. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026